<?xml version="1.0" encoding="UTF-8"?>
<ref id="B25">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Santos</surname>
    <given-names>JJS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Finch</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sutton</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Obadan</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Aguirre</surname>
    <given-names>I</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wan</surname>
    <given-names>Z</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lopez</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Geiger</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gonzalez-Reiche</surname>
    <given-names>AS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ferreri</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Perez</surname>
    <given-names>DR</given-names>
   </name>
  </person-group>
  <year>2017</year>
  <article-title>Development of an alternative modified live influenza B virus vaccine</article-title>. 
  <source>J Virol</source>
  <volume>91</volume>:
  <elocation-id>e00056-17</elocation-id>. doi:
  <pub-id pub-id-type="doi">10.1128/JVI.00056-17</pub-id>.
  <pub-id pub-id-type="pmid">28381580</pub-id>
 </mixed-citation>
</ref>
